Literature DB >> 10652445

Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide.

R Stohwasser1, J Giesebrecht, R Kraft, E C Müller, K G Häusler, H Kettenmann, U K Hanisch, P M Kloetzel.   

Abstract

The 20S proteasome is a multicatalytic threonine protease and serves to process peptides that are subsequently presented as antigenic epitopes by MHC class I molecules. In the brain, microglial cells are the major antigen presenting cells and they respond sensitive to pathologic events. We used cultured mouse microglia and a microglial cell line, the BV-2 line, as a model to study the correlation between microglial activation parameters and structural plasticity of the 20S/26S proteasome. Lipopolysaccharide (LPS)- or interferon-gamma (IFN-gamma)-stimulated microglia or BV-2 cells exhibit properties of activated microglia such as high levels of TNFalpha and IL-6 release. In response to IFN-gamma or LPS, three constitutive beta subunits (beta1/Delta, beta2/MC14, beta5/MB1) were replaced by the immunoproteasome subunits ibeta1/LMP2, ibeta2/MECL-1, and ibeta5/LMP7, indicating that activated microglia adapts its proteasomal subunit composition to the requirements of an optimized MHC class I epitope processing. Induction of immunoproteasomes in BV-2 cells was solely provoked by IFN-gamma, but not by LPS. Moreover, LPS (but not IFN-gamma) triggered the expression of a novel protein of approximately 50 kD as part of the proteasome activator PA700, that is the substrate-recognizing and unfolding unit of the 26S proteasome. These results indicate that both the 20S core protease as well as the proteasome activator PA700 are targets of modulatory subunit replacements or transient association of regulatory components in the course of microglial activation. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652445

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  20 in total

Review 1.  Microglial functions and proteases.

Authors:  Hiroshi Nakanishi
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

2.  Dextran sulfate sodium-induced colitis is associated with enhanced low molecular mass polypeptide 2 (LMP2) expression and is attenuated in LMP2 knockout mice.

Authors:  Leo R Fitzpatrick; Vineeta Khare; Jeffrey S Small; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 3.  Microglia.

Authors:  Denise van Rossum; Uwe-Karsten Hanisch
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

4.  Immunoproteasome responds to injury in the retina and brain.

Authors:  Deborah A Ferrington; Stacy A Hussong; Heidi Roehrich; Rebecca J Kapphahn; Shannon M Kavanaugh; Neal D Heuss; Dale S Gregerson
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

5.  Morphine alters M. bovis infected microglia's ability to activate γδ T lymphocytes.

Authors:  Michael Olin; Keumhwa Choi; Thomas W Molitor
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-01       Impact factor: 4.147

Review 6.  The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Rebecca A Sosa; Thomas G Forsthuber
Journal:  J Interferon Cytokine Res       Date:  2011-09-15       Impact factor: 2.607

7.  TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.

Authors:  Ismini E Papageorgiou; Andrea Lewen; Lukas V Galow; Tiziana Cesetti; Jörg Scheffel; Tommy Regen; Uwe-Karsten Hanisch; Oliver Kann
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

8.  Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.

Authors:  Michele Mishto; Elena Bellavista; Claudia Ligorio; Kathrin Textoris-Taube; Aurelia Santoro; Mara Giordano; Sandra D'Alfonso; Florinda Listì; Benedetta Nacmias; Elena Cellini; Maurizio Leone; Luigi M E Grimaldi; Chiara Fenoglio; Federica Esposito; Filippo Martinelli-Boneschi; Daniela Galimberti; Elio Scarpini; Ulrike Seifert; Maria Pia Amato; Calogero Caruso; Maria P Foschini; Peter M Kloetzel; Claudio Franceschi
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

9.  Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort.

Authors:  Josef Wagner; Winnie H Sim; Justine A Ellis; Eng K Ong; Anthony G Catto-Smith; Donald J S Cameron; Ruth F Bishop; Carl D Kirkwood
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

10.  Impairment of protein degradation and proteasome function in hereditary neuropathies.

Authors:  Jordan J S VerPlank; Sudarsanareddy Lokireddy; M Laura Feltri; Alfred L Goldberg; Lawrence Wrabetz
Journal:  Glia       Date:  2017-10-27       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.